University of Massachusetts, Worcester
Preventing emergent delirium in pediatric ambulatory surgery through preoperative use of intra-nasal Dexmedetomidine and oral Midazolam.
Pediatric ambulatory patients will randomly be allocated to one of two groups. Group A which will receive Dexmedetomidine intra-nasally at a dose of 1 mcg/kg, approximately 15-25 minutes before entering the operating room or Group B which will receive Midazolam orally at a dose of 0.5 mg/kg (with a maximum dose of 20 mg), approximately 10-15 minutes before entering the operating room. Each subject will receive a Drug Acceptance scale, and Parental Separation Anxiety Scale (PSAS) mask Acceptance Scale to identify the differences in markers associated with pediatric delirium. End tidal Sevoflura…
Inclusion Criteria: * Subjects age 3 months to 9 years * Scheduled to undergo a myringotomy * American Society of Anesthesiologists (ASA) classification of I - II. Exclusion Criteria: * Subjects with unrepaired cardiac defects, including cyanotic congenital heart disease. * Anyone age 10 years or older. * Anyone with an ASA classification of III or higher. * Non-English language speaker for whom short form consent is not available.
Subjects will receive Dexmedetomidine intra-nasally in the preoperative area. It will be administered at a dose of 1 mcg/kg, approximately 15-25 minutes before entering the operating room.
Subjects will receive Midazolam orally in the preoperative area. It will be administered at a dose of 0.5 mg/kg (with a maximum dose of 20 mg), approximately 10-15 minutes before entering the operating room.
Arctuva estimate
Actual pay is set by the research site.
Verify or correct the compensation shown for this listing.